Neonatal TPN Starter Bags Recalled Over Sterility Assurance Concerns
Central Admixture Pharmacy Services is recalling 108 Neonatal TPN Starter Bags (Lot 36-256338) due to lack of assurance of sterility and insufficient validation data for decontamination cycles.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Class II recall of a neonatal IV medication with lack of sterility assurance and insufficient decontamination validation data. No illnesses or injuries reported; hazard is theoretical but significant for this high-risk product category.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 108 Neonatal TPN Starter Bags (Amino Acids 3.5% / Dextrose 10%, 250 mL IV bags) distributed nationwide. The recall is due to lack of assurance of sterility and insufficient validation data for decontamination cycles.
The affected lot (36-256338, expiration 7/29/2023) is an Rx-only product. The firm identified that validation data for the decontamination cycles is lacking, which raises concerns about sterility assurance for this neonatal intravenous medication.
Healthcare providers who received this product should stop use and contact the manufacturer or FDA with any questions or if any adverse events occur.
The recalled product
- Product
- Neonatal TPN Starter Bag, Amino Acids (trophamine) 3.5%/Dextrose 10%, total volume = 250mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0406-1
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Hazard
- lack-of-sterility
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 36-256338
- Exp. 7/29/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27